Characterisation of COPD heterogeneity in the ECLIPSE cohort

Respiratory Research

Volumn 11, Issue , 2010, Pages

  Agusti, Alvar ^a   Calverley, Peter M A ^b   Celli, Bartolome ^c   Coxson, Harvey O ^d   Edwards, Lisa D ^e   Lomas, David A ^f   MacNee, William ^g   Miller, Bruce E ^e   Rennard, Steve ^h   Silverman, Edwin K ^c   Tal Singer, Ruth ^e   Wouters, Emiel ⁱ   Yates, Julie C ^e   Vestbo, Jørgen ^j  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e GLAXOSMITHKLINE   (United States)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^g UNIVERSITY OF EDINBURGH   (United Kingdom)

^h UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

ⁱ MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^j UNIVERSITY OF COPENHAGEN   (Denmark)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; AIRWAY OBSTRUCTION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; EMPHYSEMA; EXERCISE TOLERANCE; FEMALE; GENETIC HETEROGENEITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; SMOKING; SPIROMETRY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; LONGITUDINAL STUDY; LUNG FUNCTION TEST; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY;

ADULT; AGED; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SMOKING;

EID: 79551603829     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-11-122     Document Type: Article

References (27)

1. Global Strategy for Diagnosis, Management, and Prevention of COPD, Updated 2009. Downloaded 1st July 2010 , http://www.goldcopd.com/Guidelineitem.asp?l1=2&l2=1&intId=2003
2. Wedzicha JA. The heterogeneity of chronic obstructive pulmonary disease. Thorax 2000, 55:631-632. 10.1136/thorax.55.8.631, 1745838, 10899236.
3. Agusti AG. COPD, a multicomponent disease: implications for management. Respir Med 2005, 99:670-682. 10.1016/j.rmed.2004.11.006, 15878483.
4. Vestbo J, Anderson W, Coxson HO, Crim C, Dawber F, Edwards L, Hagan G, Knobil K, Lomas DA, MacNee W, et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). Eur Respir J 2008, 31:869-873. 10.1183/09031936.00111707, 18216052.
5. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ. The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease. N Engl J Med 2004, 350:1005-1012. 10.1056/NEJMoa021322, 14999112.
6. Han MK, Postma D, Mannino DM, Giardino ND, Buist S, Curtis JL, Martinez FJ. Gender and Chronic Obstructive Pulmonary Disease: Why It Matters. Am J Respir Crit Care Med 2007, 176:1179-1184. 10.1164/rccm.200704-553CC, 2720110, 17673696.
7. Meguro M, Barley EA, Spencer S, Jones PW. Development and Validation of an Improved, COPD-Specific Version of the St. George Respiratory Questionnaire. Chest 2007, 132:456-463. 10.1378/chest.06-0702, 17646240.
8. American Thoracic Society Official Statement. Standardization of Spirometry. 1994 Update. Am J Respir Crit Care Med 1995, 152:1107-1136.
9. ATS Statement: Guidelines for the Six-Minute Walk Test. Am J Respir Crit Care Med 2002, 166:111-117.
10. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993, 16:5-40.
11. Patel BD, Coxson HO, Pillai SG, Agusti AG, Calverley PM, Donner CF, Make BJ, Muller NL, Rennard SI, Vestbo J, et al. Airway Wall Thickening and Emphysema Show Independent Familial Aggregation in COPD. Am J Respir Crit Care Med 2008, 178:500-505. 10.1164/rccm.200801-059OC, 18565956.
12. Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J 1977, 1:1645-1648. 10.1136/bmj.1.6077.1645, 1607732, 871704.
13. Selman M, Carrillo G, Estrada A, Mejia M, Becerril C, Cisneros J, Gaxiola M, Perez-Padilla R, Navarro C, Richards T, et al. Accelerated variant of idiopathic pulmonary fibrosis: clinical behavior and gene expression pattern. PLoS ONE 2007, 2:e482. 10.1371/journal.pone.0000482, 1868965, 17534432.
14. Mannino DM, Reichert MM, Davis KJ. Lung function decline and outcomes in an adult population. Am J Respir Crit Care Med 2006, 173:985-990. 10.1164/rccm.200508-1344OC, 16439715.
15. He JQ, Foreman MG, Shumansky K, Zhang X, Akhabir L, Sin DD, Man SF, DeMeo DL, Litonjua AA, Silverman EK, et al. Associations of IL6 polymorphisms with lung function decline and COPD. Thorax 2009, 64:698-704. 10.1136/thx.2008.111278, 2859187, 19359268.
16. Kohansal R, Martinez-Camblor P, Agusti A, Buist AS, Mannino DM, Soriano JB. The Natural History of Chronic Airflow Obstruction Revisited: An Analysis of the Framingham Offspring Cohort. Am J Respir Crit Care Med 2009, 180:3-10. 10.1164/rccm.200901-0047OC, 19342411.
17. Jones PW. Issues concerning health-related quality of life in COPD. Chest 1995, 107(Suppl):187S-193S. 10.1378/chest.107.5_Supplement.187S, 7743825.
18. Halpin D. NICE guidance for COPD. Thorax 2004, 59:181-182. 10.1136/thx.2004.021113, 1746957, 14985544.
19. O'Reilly J, Jones MM, Parnham J, Lovibond K, Rudolf M. Management of stable chronic obstructive pulmonary disease in primary and secondary care: summary of updated NICE guidance. Brit Med J 2010, 340:c3134. 10.1136/bmj.c3134, 20581031.
20. Burgel PR, Nesme-Meyer P, Chanez P, Caillaud D, Carre P, Perez T, Roche N. Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects. Chest 2009, 135:975-982. 10.1378/chest.08-2062, 19017866.
21. Schols AM, Broekhuizen R, Weling-Scheepers CA, Wouters EF. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005, 82:53-59.
22. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009, 33:1165-1185. 10.1183/09031936.00128008, 19407051.
23. Patel IS, Vlahos I, Wilkinson TM, Lloyd-Owen SJ, Donaldson GC, Wilks M, Reznek RH, Wedzicha JA. Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004, 170:400-407. 10.1164/rccm.200305-648OC, 15130905.
24. Prescott E, Bjerg AM, Andersen PK, Lange P, Vestbo J. Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Eur Respir J 1997, 10:822-827.
25. de Torres JP, Casanova C, Hernandez C, Abreu J, Aguirre-Jaime A, Celli BR. Gender and COPD in patients attending a pulmonary clinic. Chest 2005, 128:2012-2016. 10.1378/chest.128.4.2012, 16236849.
26. Burgel PR, Paillasseur JL, Caillaud D, Tillie-Leblond I, Chanez P, Escamilla R, Court-Fortune I, Perez T, Carré P, Roche N. Clinical COPD phenotypes: a novel approach using principal component and cluster analyses. Eur Respir J 2010,
27. Han MK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL, Fabbri LM, Goldin JG, Jones PW, MacNee W, et al. COPD Phenotypes: The Future of COPD. Am J Respir Crit Care Med 2010, 182(5):598-604. 10.1164/rccm.200912-1843CC, 20522794.